Antimicrobial Resistance Could Claim 39 Million Lives Worldwide Over the Next 25 Years: WHO

Could drug-resistant infections become one of the world’s leading causes of preventable deaths? The World Health Organization (WHO) has warned that antimicrobial resistance (AMR) could directly cause 39 million deaths worldwide over the next 25 years, threatening routine medical procedures, surgeries and childbirth.

The UN health agency cautioned that global efforts to prevent, diagnose and control antimicrobial resistance remain too slow to meet international targets. It also stressed the need for stronger healthcare systems and responsible use of antibiotics and other antimicrobial medicines.

Antimicrobial Resistance Threatens Modern Medicine

Antimicrobial resistance occurs when bacteria, viruses, fungi and parasites develop the ability to resist medicines designed to treat the infections they cause. As a result, infections become harder to treat, increasing the risk of severe illness, complications and death.

Jean-Pierre Nyemazi, Acting Director of WHO’s Antimicrobial Resistance Department, described the growing threat as a major challenge to the future of modern medicine. He noted that, unlike highly visible health emergencies such as COVID-19, drug-resistant infections have been claiming lives for years without receiving sufficient attention.

Also Read |  New Cholera Strain Challenges Global Antibiotic Treatments

According to WHO estimates, antimicrobial resistance was directly responsible for more than one million deaths in 2021 and associated with approximately 4.7 million additional deaths.

Global Progress Against Drug Resistance Remains Slow

A WHO assessment of 183 countries conducted in 2026 found that nearly nine out of 10 countries had developed national action plans to address antimicrobial resistance. This marks considerable progress compared with 2017, when only around four in 10 countries had such plans.

However, implementation remains a major challenge. Only 42 countries, representing fewer than one in five, had plans that were adequately financed, implemented and monitored.

Pravasha Prakash, an AMR Technical Officer at WHO, said countries were making progress but needed to accelerate their efforts to achieve the global targets set for 2030.

One in Six Bacterial Infections Shows Antibiotic Resistance

The latest WHO global surveillance data reveal the growing scale of the problem. In 2023, one in every six laboratory-confirmed bacterial infections reported to the organisation was resistant to the antibiotics used to treat it.

Also Read |  Abbott’s FDA-Cleared Ultreon 3.0 Redefines Imaging in Coronary Interventions

Sylvia Bertagnolo, WHO’s Head of Antimicrobial Resistance Surveillance, emphasised the importance of diagnostic testing in guiding treatment decisions. Without appropriate testing, healthcare professionals may have to prescribe antibiotics without knowing the exact cause of an infection or which medicine will be effective.

WHO Introduces New Tools to Strengthen Diagnosis

To improve the global response, WHO has announced two new tools to help countries strengthen their diagnostic capabilities.

The first tool outlines the essential diagnostic tests that healthcare facilities should offer at every level, ranging from primary healthcare centres to referral hospitals.

The second provides a collection of 73 laboratory procedures covering the entire diagnostic process, including sample collection, pathogen identification and antibiotic susceptibility testing.

These resources aim to help healthcare professionals identify drug-resistant infections more accurately and select appropriate treatments.

Prevention and Responsible Antibiotic Use Remain Key

WHO has emphasised that tackling antimicrobial resistance requires coordinated action across healthcare systems and communities. Key measures include strengthening infection prevention and control, expanding vaccination coverage, improving access to clean water and sanitation, and ensuring the responsible use of antibiotics and other antimicrobial medicines.

Also Read |  Mammograms May Reveal Hidden Heart Disease Risks in Women

As drug resistance continues to rise, stronger surveillance, timely diagnosis and effective prevention strategies will be essential to protect public health and preserve the effectiveness of existing medicines. As reported by aljazeera.com, WHO has warned that accelerating global action is critical to reducing the growing threat of antimicrobial resistance and protecting the future of modern medicine.